The University of Chicago Header Logo

Search Results (5)

MatchTypeWhy
United States Department of DefenseConcept Why?
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.Academic Article Why?
Karrison, TheodorePerson Why?
O'Donnell, Peter H.Person Why?
Shevrin, DanielPerson Why?
Stadler, Walter M.Person Why?
Szmulewitz, Russell Z.Person Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • United States Department of Defense
Filter by Type
_
Click "Why?" to see why an item matched the search.